PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies

Researchers find a modifier of histone protein and its regulator that slows cancer growth in high-risk leukemia

2025-06-25
(Press-News.org)

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have improved outcomes for some patients, many forms of AML remain resistant to treatment, and relapses are common.

 

A new study sheds light on why certain types of AML are so challenging to treat and how outcomes for patients might be improved. Researchers from Japan, including scientists from Chiba University, have discovered that an epigenetic enzyme called SETD1B plays a critical role in supporting the growth of a particularly aggressive form of AML—especially in patients with the Fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) mutation, a genetic change associated with poor prognosis and high relapse rates. By targeting SETD1B, the researchers believe, it may be possible to develop more effective treatments that prevent leukemia cells from multiplying.

 

The study was led by Associate Professor Takayuki Hoshii and included Dr. Shintaro Izumi and Professor Atsushi Kaneda from the Graduate School of Medicine, Chiba University, Japan. The findings were published online in the journal Leukemia on May 8, 2025.

 

“Patients with AML, especially with the FLT3-ITD mutation, often respond poorly to current therapies. Our findings are that the epigenetic regulator SETD1B protein supports aggressive cell proliferation in AML by promoting oncogenic MYC expression,” says Dr. Hoshii.

 

Previous research has shown that FLT3-ITD mutations are detected in patients with mixed-lineage leukemia-rearranged (MLL-r) AML, a subtype of leukemia characterized by genetic abnormalities. MLL-r AML cells exhibit high levels of histone H3 lysine 4 trimethylation (H3K4me3), an epigenetic modification that affects which genes are turned on or off without changing the DNA sequence.  Though the link between MLL-r AML and H3K4me3 has been established, the association between FLT3-ITD and H3K4me3 remains unclear.

 

Using advanced genetic screening tools, the team identified Setd1b as the gene responsible for producing a protein that adds methyl groups to histone H3 at lysine 4, resulting in the H3K4me3 epigenetic modification, and upregulation of Myc genes, which plays a critical role in regulating cell growth, division, and metabolism and can contribute to cancer development if altered.

 

To understand the role of SETD1B, the researchers performed CRISPR screening and then genetically engineered leukemia cells with altered versions of SETD1B, specifically deleting its catalytic domain, which is the active part of the protein responsible for the epigenetic modification of the DNA. They then used RNA sequencing and chromatin mapping to identify which genes and pathways were most affected.

 

Their experiments revealed that removing SETD1B’s catalytic domain significantly slowed cancer growth, particularly in leukemia cells with FLT3-ITD or NrasG12D mutations. It also caused a drop in the activity of genes in the MYC pathway. This suggests that without the epigenetic function of SETD1B, MYC cannot remain fully active, weakening the ability of the cancer cells to grow and divide.

 

“The breadth of H3K4me3 is crucial for transcriptional consistency, and MYC expression appears highly dependent on both the quality and quantity of transcriptional elongation,” says Dr. Hoshii. “Understanding SETD1B’s role in maintaining this epigenetic mark is critical for developing biomarkers and therapies for leukemia subtypes and other MYC-driven cancers.”

 

Interestingly, when the researchers reintroduced the Myc gene back into leukemia cells lacking SETD1B, the cancer cells began to grow again, but only partially, suggesting that SETD1B plays a broader role in MYC’s cancer-promoting activity.

 

This discovery paves the way for new treatment strategies. By targeting SETD1B or its epigenetic functions, scientists may be able to develop therapies that are especially effective for patients with FLT3-ITD mutations. As a possible next step, the researchers point to Chaetocin, an existing compound known to inhibit enzymes related to SETD1B. This could serve as a foundation for developing more selective SETD1B-targeted drugs. Measuring SETD1B activity in patients might also help doctors predict who would benefit most from these therapies.

 

As the search for better treatments continues, this study reveals how targeting the cancer’s epigenetic machinery could provide a new strategy to treat the disease, giving hope to patients with aggressive forms of AML.

 

 

 

About Associate Professor Takayuki Hoshii

Dr. Takayuki Hoshii is an Associate Professor at the Graduate School of Medicine, Chiba University. His research focuses on how epigenetic mechanisms drive childhood leukemia, particularly through abnormal transcriptional regulation. By investigating factors like chromatin modification and MYC expression, Dr. Hoshii aims to identify novel therapeutic targets. He recently revealed how key proteins function during the “set” phase of gene transcription, contributing to cancer progression. He is a member of several academic societies, including the Japanese Society of Hematology and the Japanese Society for Epigenetics, and approaches research with the philosophy: “Keep making hypotheses, keep discarding hypotheses, and value the results.”

END



ELSE PRESS RELEASES FROM THIS DATE:

Uncovering the role of vitamin C in skin regeneration

2025-06-25
The skin acts as the body’s first line of defense against external threats. However, as we age, the epidermis—the outermost layer of skin—gradually becomes thinner and loses its protective strength. About 90% of the cells in this layer are keratinocytes, which originate from deeper layers of the epidermis and migrate upward, ultimately forming the skin’s protective barrier. To combat aging’s impact on skin, numerous studies have emphasized the benefits of vitamin C (VC), a vitamin well known for its role in skin health and antioxidant ...

Advancing regenerative agriculture: TUdi unveils new digital tools for soil health monitoring

2025-06-25
Technology plays a pivotal role across industries today, and agriculture is no exception. In the realm of regenerative agriculture - an approach focused on conserving and restoring soil health and biodiversity - technology is key in enhancing data collection, monitoring, and supporting informed decision-making.  TUdi is a collaborative project between the European Union and China funded by the European Commission and the Chinese Ministry of Science and Technology, within the Horizon 2020 programme. The project's goal is to develop and promote soil-restoration strategies ...

More staff addressing mental health in schools buffers toll of growing up in disadvantaged communities

2025-06-25
Children growing up in disadvantaged neighborhoods—communities with low rates of high school graduation and employment, low family income, and other measures of adversity—are at heightened risk of experiencing mental health conditions. But a new study from Mass General Brigham suggests that, while neighborhood environment plays a key role in mental health, having greater access to mental health staff in schools could help lower risk.   In a study of 30,000 high school and middle school students at 62 schools ...

Still top cause of death, the types of heart disease people are dying from is changing

2025-06-25
Research Highlights: Over the past 50 years, overall heart disease death rates have dropped by 66% and deaths from heart attacks have declined by nearly 90%. The types of heart disease people are dying from most often have shifted from heart attacks to an increase in deaths from heart failure, arrhythmias and hypertensive heart disease. Researchers say this shift, in part, is the result of advances in public health measures focused on prevention and life-saving interventions to improve early diagnosis and treatment, allowing people to live longer while managing chronic heart conditions   DALLAS, June 25, 2025 — While heart disease has been the leading ...

Scientists detect deep Earth pulses beneath Africa

2025-06-25
Research led by Earth scientists at the University of Southampton has uncovered evidence of rhythmic surges of molten mantle rock rising from deep within the Earth beneath Africa. These pulses are gradually tearing the continent apart and forming a new ocean. The findings, published in Nature Geoscience, reveal that the Afar region in Ethiopia is underlain by a plume of hot mantle that pulses upward like a beating heart. The team’s discovery reveals how the upward flow of hot material from the deep mantle is strongly influenced by the tectonic plates – the massive solid slabs ...

As fewer Americans die from heart attacks, more succumb to chronic heart disease

2025-06-25
In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving the hospital alive. Today, the survival rate is over 90%, with even better outcomes for younger patients. Those numbers have contributed to a remarkable decrease in the likelihood of dying from any type of heart disease over the last 50 years, according to a new study of heart disease mortality led by Stanford Medicine researchers. In 1970, 41% of all deaths were attributed to ailments of the heart; in 2022, that statistic had dropped to 24% of all deaths.  Most strikingly, the proportion ...

Guidance issued for GPs managing weight-loss injection patients

2025-06-25
Academics at King’s College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs. The medications are not routinely prescribed for obesity management in primary care. But it is estimated 1.5million people used weight-loss jabs in March 2025 with 80% of purchases through online retailers. As these users are privately accessing the medication, providers do not always provide wrap-around care such as dietary advice or psychological support. The authors of the guidance, published today in Obesity Facts, say the ten evidence-based tips aim to help GPs who see patients using ...

Low-cost carbon capture? Bury wood debris in managed forests

2025-06-25
CORNELL UNIVERSITY MEDIA RELATIONS OFFICE FOR RELEASE: June 25, 2025   Kaitlyn Serrao 607-882-1140 kms465@cornell.edu Low-cost carbon capture? Bury wood debris in managed forests ITHACA, N.Y. – Taking carbon out of the atmosphere is essential for slowing global warming – and a team of Cornell University researchers has estimated “huge” potential for carbon capture using a method that is low-tech, sustainable and relatively simple: burying wood, especially the debris from managed ...

Scientists unravel mystery of Mycetoma grain formation

2025-06-25
Osaka, Japan – A groundbreaking study led by a global research consortium offers new hope for patients with mycetoma, a neglected tropical disease. Researchers using an insect model and transcriptome analysis have unravelled the mechanism of iron regulation between host tissue and the mycetoma grain, a fungal mass characteristic of the disease. This discovery illuminates how the causative fungus invades and develops these protective grains within subcutaneous tissue, paving the way for new drug development and less invasive treatment strategies beyond surgical removal, potentially reducing the burden on patients significantly. Mycetoma, a chronic infectious ...

Exposure to particulate matter during pregnancy is associated with an increased risk of childhood obesity

2025-06-25
Exposure to air pollution during pregnancy, specifically to fine particulate matter (PM2.5), may increase the risk of childhood overweight or obesity. This is the conclusion of a large, pan-European meta-analysis study led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the ”la Caixa” Foundation, and recently published in Environment International. The study examined the relationship between exposure to air pollutants during pregnancy and during childhood, and its impact on body mass index (BMI) and ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies
Researchers find a modifier of histone protein and its regulator that slows cancer growth in high-risk leukemia